Immunogenic Potential of DNA Vaccine candidate, ZyCoV-D against SARS-CoV-2 in Animal Models

@article{Dey2021ImmunogenicPO,
  title={Immunogenic Potential of DNA Vaccine candidate, ZyCoV-D against SARS-CoV-2 in Animal Models},
  author={A. Dey and T. M. Chozhavel Rajanathan and H. Chandra and Hari P.R. Pericherla and Sanjeev Kumar and H. S. Choonia and M. Bajpai and A. K. Singh and Anuradha Sinha and Gurwinder Saini and P. Dalal and Sarosh Vandriwala and M. A. Raheem and Rupesh D. Divate and Neelam L. Navlani and Vibhuti Sharma and Aashini Parikh and S. Prasath and Sankar Rao and K. Maithal},
  journal={bioRxiv},
  year={2021}
}
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), initially originated in China in year 2019 and spread rapidly across the globe within 5 months, causing over 96 million cases of infection and over 2 million deaths. Huge efforts were undertaken to bring the COVID-19 vaccines in clinical development, so that it can be made available at the earliest, if found to be efficacious in the trials. We developed a candidate vaccine ZyCoV-D comprising of a DNA plasmid vector carrying the gene… Expand

References

SHOWING 1-10 OF 36 REFERENCES
Immunogenicity of a DNA vaccine candidate for COVID-19
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
A pneumonia outbreak associated with a new coronavirus of probable bat origin
...
1
2
3
4
...